INAB compared with GOSS: revenue, margins and what each company keeps, and the suppliers and customers both name

INABIN8BIO, Inc.

Mkt capRevenueRevenue

GOSSGossamer Bio, Inc.

Mkt capRevenueRevenue

Compare

INABIN8BIO, Inc.

GOSSGossamer Bio, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

INAB: latest quarter not drawable. GOSS: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only INAB 0

None

Shared 0

No disclosed counterparties: INAB.

Only GOSS 3

—Chiesiunlistedcustomer

—Pulmokineunlistedsupplier

—Respira Therapeuticsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

INAB, solidGOSS, dashed

INABIN8BIO, Inc.

0.94▼−4.09%· post 0.94

Mkt cap$8.9MRevenue—Revenue—

GOSSGossamer Bio, Inc.

10.35▼−3.17%· post 10.20

ClosedOct 30 '26

Mkt cap$63.4MRevenue$9MQ2 FY26Revenue$48MFY25

Compare

ClosedOct 30 '26

INABIN8BIO, Inc.

GOSSGossamer Bio, Inc.

0.94▼−4.09%post 0.94

Price

10.35▼−3.17%post 10.20

$8.9M

Mkt cap

$63.4M

—

Revenue

$9MQ2 FY26

—

Revenue

$48MFY25

INAB0.94▼−4.09%vsGOSS10.35▼−3.17%ClosedOct 30 '26